Results 261 to 270 of about 361,176 (290)

Ciprofloxacin/dexamethasone/dexamethasone

Reactions Weekly, 2018
openaire   +1 more source

Dexamethasone see Prednisone/dexamethasone

Reactions Weekly, 1990
openaire   +1 more source

Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study

Lancet, The, 2020
Athanasios Dimopoulos, Hang Quach, María-Victoria Mateos   +2 more
exaly  

Dexamethasone in Hospitalized Patients with Covid-19

New England Journal of Medicine, 2021
Peter W Horby, Wei Shen Lim, Jonathan R Emberson   +2 more
exaly  

Dexamethasone

Reactions Weekly
  +6 more sources

Dexamethasone see Vincristine/dexamethasone

Reactions Weekly, 1991
openaire   +1 more source

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

Lancet, The, 2019
Paul G Richardson, S Vincent Rajkumar, Jesus San Miguel   +2 more
exaly  

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial

Lancet, The, 2017
Jesus San Miguel, Muneer H Abidi, S Vincent Rajkumar   +2 more
exaly  

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Lancet, The, 2010
Michele Cavo, Francesca Patriarca, Maria Teresa Petrucci   +2 more
exaly  

Dexamethasone in bronchiolitis: a randomised controlled trial

Lancet, The, 1996
Karen M Sheehan
exaly